The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure

FEBS Letters

Volumn 459, Issue 3, 1999, Pages 367-376

  Babenko, Andrey P ^a   Gonzalez, Gabriela ^a   Bryan, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ATP binding cassette; ATP sensitive potassium inward rectifier; Gating; K(IR)6.0; SUR2A; Transport ATPase

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; MAGNESIUM ION; NUCLEOTIDE; POTASSIUM CHANNEL; SULFONYLUREA; TOLBUTAMIDE;

ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; ION CURRENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; COS CELLS; HUMANS; HYPOGLYCEMIC AGENTS; NUCLEOTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; RECOMBINANT FUSION PROTEINS; SULFONYLUREA COMPOUNDS; TOLBUTAMIDE;

EID: 0032834155     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01215-6     Document Type: Article

References (51)

1. Sturgess N.C., Ashford M.L., Cook D.L., Hales C.N. Lancet. 2:1985;474-575.
2. Loubatieres M.M. Rev. Prat. 42:1992;2600-2602.
3. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.P. IV, Boyd A.E. III, Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D.A. Science. 268:1995;423-426.
4. Inagaki N., Gonoi T., Clement J.P. IV, Namba N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., Bryan J. Science. 270:1995;1166-1170.
5. Clement J.P. IV, Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., Bryan J. Neuron. 18:1997;827-838.
6. Shyng S., Nichols C.G. J. Gen. Physiol. 110:1997;655-664.
7. Babenko, A.P., Sharma, N., Aguilar-Bryan, L., Gonzalez, G. and Bryan, J. (1999) Diabetes (in press).
8. Babenko A.P., Aguilar-Bryan L., Bryan J. Annu. Rev. Physiol. 60:1998;667-687.
9. Zunkler B.J., Lins S., Ohno-Shosaku T., Trube G., Panten U. FEBS Lett. 239:1988;241-244.
10. Venkatesh N., Lamp S.T., Weiss J.N. Circ. Res. 69:1991;623-637.
11. Inagaki N., Gonoi T., Clement J.P., Wang C.Z., Aguilar-Bryan L., Bryan J., Seino S. Neuron. 16:1996;1011-1017.
12. Malaisse W.J. Pharmacol. Res. 32:1995;111-114.
13. Grell W., Hurnaus R., Griss G., Sauter R., Rupprecht E., Mark M., Luger P., Nar H., Wittneben H., Muller P.W. J. Med. Chem. 41:1998;5219-5246.
14. Gillis K.D., Gee W.M., Hammoud A., McDaniel M.L., Falke L.C., Misler S. Am. J. Physiol. 257:1989;C1119-C1127.
15. Schwanstecher C., Dickel C., Panten U. Mol. Pharmacol. 41:1992;480-486.
16. Gribble F.M., Tucker S.J., Ashcroft F.M. J. Physiol. (Lond.). 504:1997;35-45.
17. Gribble F.M., Tucker S.J., Seino S., Ashcroft F.M. Diabetes. 47:1998;1412-1418.
18. Ueda K., Komine J., Matsuo M., Seino S., Amachi T. Proc. Natl. Acad. Sci. USA. 96:1999;1268-1272.
19. Babenko A.P., Gonzalez G., Bryan J. Biochem. Biophys. Res. Commun. 255:1999;231-238.
20. Babenko A.P., Bryan J. Biophys. J. 76:1999;A14.
21. Aguilar-Bryan L., Clement J.P.T., Gonzalez G., Kunjilwar K., Babenko A., Bryan J. Physiol. Rev. 78:1998;227-245.
22. Babenko A.P., Gonzalez G., Aguilar-Bryan L., Bryan J. FEBS Lett. 445:1999;131-136.
23. Babenko A.P., Gonzalez G., Bryan J. J. Biol. Chem. 274:1999;11587-11592.
24. Babenko A.P., Gonzalez G., Aguilar-Bryan L., Bryan J. Circ. Res. 83:1998;1132-1143.
25. Fabiato A. Methods Enzymol. 157:1988;378-417.
26. Dorschner H., Brekardin E., Uhde I., Schwanstecher C., Schwanstecher M. Mol. Pharmacol. 55:1999;1060-1066.
27. Nichols C.G., Shyng S.L., Nestorowicz A., Glaser B., Clement J.P. IV, Gonzalez G., Aguilar-Bryan L., Permutt M.A., Bryan J. Science. 272:1996;1785-1787.
28. Ashfield R., Gribble F.M., Ashcroft S.J., Ashcroft F.M. Diabetes. 48:1999;1341-1347.
29. Alekseev A.E., Brady P.A., Terzic A. J. Gen. Physiol. 111:1998;381-394.
30. Trapp S., Proks P., Tucker S.J., Ashcroft F.M. J. Gen. Physiol. 112:1998;333-349.
31. Koster J.C., Sha Q., Shyng S., Nichols C.G. J. Physiol. (Lond.). 515:1999;19-30.
32. Thuringer D., Cavero I., Coraboeuf E. Br. J. Pharmacol. 115:1995;117-127.
33. Schwanstecher C., Dickel C., Panten U. Br. J. Pharmacol. 111:1994;302-310.
34. Cook D.L., Hales C.N. Nature. 311:1984;271-273.
35. Zunkler B.J., Trube G., Panten U. Naunyn. Schmiedebergs. Arch. Pharmacol. 340:1989;328-332.
36. Aguilar-Bryan, L. and Bryan, J. (1999) in: Diabetes Mellitus (LeRoith, D., Taylor, S.I. and Olefsky, J.M., Eds.), Lippencott-Raven Publishers, Philadelphia (in press).
37. Fosset M., De Weille J.R., Green R.D., Schmid-Antomarchi H., Lazdunski M. J. Biol. Chem. 263:1988;7933-7936.
38. Gopalakrishnan M., Johnson D.E., Janis R.A., Triggle D.J. J. Pharmacol. Exp. Ther. 257:1991;1162-1171.
39. Liu Y., Holmgren M., Jurman M.E., Yellen G. Neuron. 19:1997;175-184.
40. Doyle D.A., Morais Cabral J., Pfuetzner R.A., Kuo A., Gulbis J.M., Cohen S.L., Chait B.T., MacKinnon R. Science. 280:1998;69-77.
41. Perozo E., Cortes D.M., Cuello L.G. Science. 285:1999;73-78.
42. Chang G., Spencer R.H., Lee A.T., Barclay M.T., Rees D.C. Science. 282:1998;2220-2226.
43. Gromada J., Dissing S., Kofod H., Frokjaer-Jensen J. Diabetologia. 38:1995;1025-1032.
44. Schwanstecher M., Loser S., Rietze I., Panten U. Naunyn. Schmiedebergs. Arch. Pharmacol. 343:1991;83-89.
45. Gribble F.M., Tucker S.J., Ashcroft F.M. EMBO J. 16:1997;1145-1152.
46. Gribble F.M., Tucker S.J., Haug T., Ashcroft F.M. Proc. Natl. Acad. Sci. USA. 95:1998;7185-7190.
47. Zerangue N., Schwappach B., Jan Y.N., Jan L.Y. Neuron. 22:1999;537-548.
48. Minor D.L. Jr., Masseling S.J., Jan Y.N., Jan L.Y. Cell. 96:1999;879-891.
49. Roux B., MacKinnon R. Science. 285:1999;100-102.
50. Loussouarn G., Makhina E.N., Nichols C.G. Biophys. J. 76:1999;A73.
51. Drain P., Li L., Wang J. Proc. Natl. Acad. Sci. USA. 95:1998;13953-13958.